Bcl-2-associated death promoter
Bcl-2-associated death promoter (BAD) is a pro-apoptotic member of the Bcl-2 family of proteins. It plays a crucial role in the regulation of apoptosis, a form of programmed cell death, by promoting cell death in response to various cellular stress signals.
Structure
BAD is a member of the Bcl-2 family, which is characterized by the presence of one or more Bcl-2 homology domains (BH domains). BAD contains the BH3 domain, which is essential for its pro-apoptotic activity. The BH3 domain allows BAD to interact with and neutralize anti-apoptotic proteins such as Bcl-2 and Bcl-xL, thereby promoting apoptosis.
Function
BAD promotes apoptosis by binding to and inhibiting the function of anti-apoptotic Bcl-2 family members. This interaction releases pro-apoptotic factors such as Bax and Bak, which then oligomerize and form pores in the mitochondrial outer membrane. This leads to the release of cytochrome c and other pro-apoptotic factors from the mitochondria into the cytosol, triggering the activation of caspases and the execution of apoptosis.
Regulation
The activity of BAD is regulated by phosphorylation. When BAD is phosphorylated by kinases such as Akt or Protein kinase A, it is sequestered in the cytosol by binding to 14-3-3 proteins, which prevents it from interacting with Bcl-2 and Bcl-xL. Dephosphorylation of BAD, on the other hand, allows it to translocate to the mitochondria and promote apoptosis.
Clinical Significance
Dysregulation of BAD and other Bcl-2 family members is implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Overexpression of anti-apoptotic Bcl-2 family proteins can lead to resistance to apoptosis, contributing to the survival and proliferation of cancer cells. Conversely, enhancing the pro-apoptotic activity of BAD is being explored as a potential therapeutic strategy for inducing cell death in cancer cells.
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
